BEAT News and Press, Heartbeam Inc. From 08/11/22

The following slide deck was published by HeartBeam, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: HeartBeam, Inc. 2022 Q2 - Results - Earnings Call Presentation

HeartBeam press release ( NASDAQ: BEAT ): Q2 GAAP EPS of $0.43 beats by $0.70 . Shares -2.6% . For further details see: HeartBeam GAAP EPS of $0.43 beats by $0.70

Company Remains on Track for FDA Submissions of the HeartBeam AIMI™ Software Platform for the Emergency Department in Q3 2022 & AIMIGo™, the Telehealth Solution, in Q4 2022 Acquires Source Code Access Under the LivMor Partnership Agreement that will be Used t...

Company Hires Cardiac Industry Veteran to Lead Technology Development HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today the appointment of Ken Persen to ...

Annual Awards Program Recognizes State-of-the-Art Cardiac Technologies HeartBeam, Inc . (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, was selected as winner of the annual Cardio...

HeartBeam, Inc . (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, will hold a conference call on Thursday August 11, 2022 at 4:30 p.m. Eastern time to discuss its results for the second quarte...

Expanded Scope of Clinical Validation Study Will Provide Access to a Broader Patient Population Company Expects to File 510K No Later Than August 15, 2022 HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedi...

The following slide deck was published by HeartBeam, Inc. in conjunction with this event. For further details see: HeartBeam (BEAT) Presents at the H.C. Wainwright Global Investment Conference - Slideshow

HeartBeam, Inc . (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, will present at the in-person LD Micro Invitational XII Conference being held at the Four Seasons in Westlake Village, CA on J...

HeartBeam, Inc . (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, announced today it will participate virtually in the H.C. Wainwright Global Investment Conference being held in-person and vir...